{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:55:03Z","timestamp":1794668103340,"version":"4.9.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Oncogene-targeted cancer therapies can provide deep responses but frequently suffer from acquired resistance. Therapeutic approaches to treat tumours that have acquired drug resistance are complicated by continual tumour evolution and multiple co-occurring resistance mechanisms. Rather than treating resistance after it emerges, it may be possible to prevent it by inhibiting the adaptive processes that initiate resistance, but these are poorly understood. Here we report that residual cancer persister cells that survive oncogene-targeted therapy are growth arrested by drug stress-induced intrinsic type I interferon signalling. To escape growth arrest, persister cells leverage apoptotic machinery to transcriptionally suppress interferon-stimulated genes (ISGs). Mechanistically, persister cells sublethally engage apoptotic caspases to activate DNA endonuclease DNA fragmentation factor B (also known as caspase-activated DNase), which induces DNA damage, mutagenesis and stress response factor activating transcription factor 3 (ATF3). ATF3 limits activator protein 1-mediated ISG expression sufficiently to allow persister cell regrowth. Persister cells deficient in DNA fragmentation factor B or ATF3 exhibit high ISG expression and are consequently unable to regrow. Therefore, sublethal apoptotic stress paradoxically promotes the regrowth of residual cancer cells that survive drug treatment.<\/jats:p>","DOI":"10.1038\/s41556-025-01810-x","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T10:02:09Z","timestamp":1763373729000},"page":"2143-2151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1994-2033","authenticated-orcid":false,"given":"August F.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A. G.","family":"Gervasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Turkal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9303-3295","authenticated-orcid":false,"given":"Anna E.","family":"Stuhlfire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7937-8708","authenticated-orcid":false,"given":"Michael X.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon E.","family":"Mauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4674-0333","authenticated-orcid":false,"given":"Rhea","family":"Plawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2525-8011","authenticated-orcid":false,"given":"Ariel H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle H.","family":"Paw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1790-9776","authenticated-orcid":false,"given":"Mehrshad","family":"Hairani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cooper P.","family":"Lathrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie H.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5822-0298","authenticated-orcid":false,"given":"Jennifer L.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5008-6696","authenticated-orcid":false,"given":"Matthew J.","family":"Hangauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"1810_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nm.4040","volume":"22","author":"AN Hata","year":"2016","unstructured":"Hata, A. N. et al. Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition. Nat. Med. 22, 262\u2013269 (2016).","journal-title":"Nat. Med."},{"key":"1810_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10690","volume":"7","author":"M Ramirez","year":"2016","unstructured":"Ramirez, M. et al. Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells. Nat. Commun. 7, 10690 (2016).","journal-title":"Nat. Commun."},{"key":"1810_CR3","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1126\/science.aav4474","volume":"366","author":"M Russo","year":"2019","unstructured":"Russo, M. et al. Adaptive mutability of colorectal cancers in response to targeted therapies. Science 366, 1473\u20131480 (2019).","journal-title":"Science"},{"key":"1810_CR4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1126\/science.aau8768","volume":"368","author":"A Cipponi","year":"2020","unstructured":"Cipponi, A. et al. MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer. Science 368, 1127\u20131131 (2020).","journal-title":"Science"},{"key":"1810_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcac032","volume":"4","author":"P Channathodiyil","year":"2022","unstructured":"Channathodiyil, P. et al. Escape from G1 arrest during acute MEK inhibition drives the acquisition of drug resistance. NAR Cancer 4, zcac032 (2022).","journal-title":"NAR Cancer"},{"key":"1810_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","volume":"141","author":"SV Sharma","year":"2010","unstructured":"Sharma, S. V. et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141, 69\u201380 (2010).","journal-title":"Cell"},{"key":"1810_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer, M. J. et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature 551, 247\u2013250 (2017).","journal-title":"Nature"},{"key":"1810_CR8","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1091\/mbc.e11-11-0926","volume":"23","author":"HL Tang","year":"2012","unstructured":"Tang, H. L. et al. Cell survival, DNA damage, and oncogenic transformation after a transient and reversible apoptotic response. Mol. Biol. Cell 23, 2240\u20132252 (2012).","journal-title":"Mol. Biol. Cell"},{"key":"1810_CR9","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1016\/j.cell.2022.07.025","volume":"185","author":"H Kalkavan","year":"2022","unstructured":"Kalkavan, H. et al. Sublethal cytochrome c release generates drug-tolerant persister cells. Cell 185, 3356\u20133374.e22 (2022).","journal-title":"Cell"},{"key":"1810_CR10","doi-asserted-by":"publisher","first-page":"107731","DOI":"10.1016\/j.celrep.2020.107731","volume":"31","author":"K Berthenet","year":"2020","unstructured":"Berthenet, K. et al. Failed apoptosis enhances melanoma cancer cell aggressiveness. Cell Rep. 31, 107731 (2020).","journal-title":"Cell Rep."},{"key":"1810_CR11","doi-asserted-by":"publisher","first-page":"e2216531120","DOI":"10.1073\/pnas.2216531120","volume":"120","author":"M Nano","year":"2023","unstructured":"Nano, M., Mondo, J. A., Harwood, J., Balasanyan, V. & Montell, D. J. Cell survival following direct executioner-caspase activation. Proc. Natl Acad. Sci. USA 120, e2216531120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1810_CR12","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/cr.2017.41","volume":"27","author":"X Liu","year":"2017","unstructured":"Liu, X. et al. Self-inflicted DNA double-strand breaks sustain tumorigenicity and stemness of cancer cells. Cell Res. 27, 764\u2013783 (2017).","journal-title":"Cell Res."},{"key":"1810_CR13","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1038\/onc.2010.242","volume":"29","author":"MM Lovric","year":"2010","unstructured":"Lovric, M. M. & Hawkins, C. J. TRAIL treatment provokes mutations in surviving cells. Oncogene 29, 5048\u20135060 (2010).","journal-title":"Oncogene"},{"key":"1810_CR14","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.molcel.2015.01.018","volume":"57","author":"G Ichim","year":"2015","unstructured":"Ichim, G. et al. Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death. Mol. Cell 57, 860\u2013872 (2015).","journal-title":"Mol. Cell"},{"key":"1810_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc7480","volume":"14","author":"M Ali","year":"2022","unstructured":"Ali, M. et al. Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells. Sci. Transl. Med. 14, eabc7480 (2022).","journal-title":"Sci. Transl. Med."},{"key":"1810_CR16","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.tcb.2023.03.002","volume":"33","author":"J Benada","year":"2023","unstructured":"Benada, J., Alsowaida, D., Megeney, L. A. & S\u00f8rensen, C. S. Self-inflicted DNA breaks in cell differentiation and cancer. Trends Cell Biol. 33, 850\u2013859 (2023).","journal-title":"Trends Cell Biol."},{"key":"1810_CR17","doi-asserted-by":"publisher","first-page":"9200","DOI":"10.1074\/jbc.M112.411371","volume":"288","author":"V Iglesias-Guimarais","year":"2013","unstructured":"Iglesias-Guimarais, V. et al. Chromatin collapse during caspase-dependent apoptotic cell death requires DNA fragmentation factor, 40-kDa subunit-\/caspase-activated deoxyribonuclease-mediated 3\u2032-OH single-strand DNA breaks. J. Biol. Chem. 288, 9200\u20139215 (2013).","journal-title":"J. Biol. Chem."},{"key":"1810_CR18","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/febs.13970","volume":"284","author":"BD Larsen","year":"2017","unstructured":"Larsen, B. D. & S\u00f8rensen, C. S. The caspase-activated DNase: apoptosis and beyond. FEBS J. 284, 1160\u20131170 (2017).","journal-title":"FEBS J."},{"key":"1810_CR19","doi-asserted-by":"publisher","first-page":"13836","DOI":"10.1074\/jbc.274.20.13836","volume":"274","author":"X Liu","year":"1999","unstructured":"Liu, X., Zou, H., Widlak, P., Garrard, W. & Wang, X. Activation of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease): oligomerization and direct interaction with histone H1. J. Biol. Chem. 274, 13836\u201313840 (1999).","journal-title":"J. Biol. Chem."},{"key":"1810_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04768-y","volume":"13","author":"A Haimovici","year":"2022","unstructured":"Haimovici, A. et al. Spontaneous activity of the mitochondrial apoptosis pathway drives chromosomal defects, the appearance of micronuclei and cancer metastasis through the caspase-activated DNAse. Cell Death Dis. 13, 315 (2022).","journal-title":"Cell Death Dis."},{"key":"1810_CR21","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2019.07.009","volume":"178","author":"T Kula","year":"2019","unstructured":"Kula, T. et al. T-Scan: a genome-wide method for the systematic discovery of T cell epitopes. Cell 178, 1016\u20131028.e13 (2019).","journal-title":"Cell"},{"key":"1810_CR22","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1093\/nar\/29.19.3901","volume":"29","author":"G Meiss","year":"2001","unstructured":"Meiss, G., Scholz, S. R., Korn, C., Gimadutdinow, O. & Pingoud, A. Identification of functionally relevant histidine residues in the apoptotic nuclease CAD. Nucleic Acids Res. 29, 3901\u20133909 (2001).","journal-title":"Nucleic Acids Res."},{"key":"1810_CR23","doi-asserted-by":"publisher","first-page":"e3062","DOI":"10.1038\/cddis.2017.454","volume":"8","author":"MA Miles","year":"2017","unstructured":"Miles, M. A. & Hawkins, C. J. Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine. Cell Death Dis. 8, e3062 (2017).","journal-title":"Cell Death Dis."},{"key":"1810_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s10495-019-01543-x","volume":"24","author":"MA Miles","year":"2019","unstructured":"Miles, M. A., Harris, M. A. & Hawkins, C. J. Proteasome inhibitors trigger mutations via activation of caspases and CAD, but mutagenesis provoked by the HDAC inhibitors vorinostat and romidepsin is caspase\/CAD-independent. Apoptosis 24, 404\u2013413 (2019).","journal-title":"Apoptosis"},{"key":"1810_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-023-06303-1","volume":"620","author":"H Isozaki","year":"2023","unstructured":"Isozaki, H. et al. Therapy-induced APOBEC3A drives evolution of persistent cancer cells. Nature 620, 393\u2013401 (2023).","journal-title":"Nature"},{"key":"1810_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","volume":"14","author":"LB Ivashkiv","year":"2014","unstructured":"Ivashkiv, L. B. & Donlin, L. T. Regulation of type I interferon responses. Nat. Rev. Immunol. 14, 36\u201349 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"1810_CR27","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/s41586-023-05880-5","volume":"616","author":"J Hu","year":"2023","unstructured":"Hu, J. et al. STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma. Nature 616, 806\u2013813 (2023).","journal-title":"Nature"},{"key":"1810_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37146-z","volume":"14","author":"ST Killarney","year":"2023","unstructured":"Killarney, S. T. et al. Executioner caspases restrict mitochondrial RNA-driven Type I IFN induction during chemotherapy-induced apoptosis. Nat. Commun. 14, 1399 (2023).","journal-title":"Nat. Commun."},{"key":"1810_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.trecan.2022.09.003","volume":"9","author":"H Cheon","year":"2023","unstructured":"Cheon, H., Wang, Y., Wightman, S. M., Jackson, M. W. & Stark, G. R. How cancer cells make and respond to interferon-I. Trends Cancer 9, 83\u201392 (2023).","journal-title":"Trends Cancer"},{"key":"1810_CR30","doi-asserted-by":"publisher","first-page":"9373","DOI":"10.1073\/pnas.0903487106","volume":"106","author":"H Cheon","year":"2009","unstructured":"Cheon, H. & Stark, G. R. Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc. Natl Acad. Sci. USA 106, 9373\u20139378 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1810_CR31","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/s41418-024-01320-7","volume":"31","author":"A Moeed","year":"2024","unstructured":"Moeed, A. et al. The caspase-activated DNase drives inflammation and contributes to defense against viral infection. Cell Death Differ. 31, 924\u2013937 (2024).","journal-title":"Cell Death Differ."},{"key":"1810_CR32","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.cell.2014.11.037","volume":"159","author":"A Rongvaux","year":"2014","unstructured":"Rongvaux, A. et al. Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell 159, 1563\u20131577 (2014).","journal-title":"Cell"},{"key":"1810_CR33","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.cell.2014.11.036","volume":"159","author":"MJ White","year":"2014","unstructured":"White, M. J. et al. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell 159, 1549\u20131562 (2014).","journal-title":"Cell"},{"key":"1810_CR34","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.abi6378","volume":"376","author":"BD Larsen","year":"2022","unstructured":"Larsen, B. D. et al. Cancer cells use self-inflicted DNA breaks to evade growth limits imposed by genotoxic stress. Science 376, 476\u2013483 (2022).","journal-title":"Science"},{"key":"1810_CR35","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1073\/pnas.0913089107","volume":"107","author":"BD Larsen","year":"2010","unstructured":"Larsen, B. D. et al. Caspase 3\/caspase-activated DNase promote cell differentiation by inducing DNA strand breaks. Proc. Natl Acad. Sci. USA 107, 4230\u20134235 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1810_CR36","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.4049\/jimmunol.1500204","volume":"195","author":"LI Labzin","year":"2015","unstructured":"Labzin, L. I. et al. ATF3 is a key regulator of macrophage IFN responses. J. Immunol. 195, 4446\u20134455 (2015).","journal-title":"J. Immunol."},{"key":"1810_CR37","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.4049\/jimmunol.1302411","volume":"192","author":"X Cai","year":"2014","unstructured":"Cai, X., Xu, Y., Kim, Y.-M., Loureiro, J. & Huang, Q. PIKfyve, a class III lipid kinase, is required for TLR-induced type I IFN production via modulation of ATF3. J. Immunol. 192, 3383\u20133389 (2014).","journal-title":"J. Immunol."},{"key":"1810_CR38","doi-asserted-by":"publisher","first-page":"e01055","DOI":"10.1128\/jvi.01055-24","volume":"98","author":"P Badu","year":"2024","unstructured":"Badu, P., Baniulyte, G., Sammons, M. A. & Pager, C. T. Activation of ATF3 via the integrated stress response pathway regulates innate immune response to restrict Zika virus. J. Virol. 98, e01055\u201324 (2024).","journal-title":"J. Virol."},{"key":"1810_CR39","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/s43587-024-00745-6","volume":"4","author":"J Mao","year":"2024","unstructured":"Mao, J. et al. Reactivation of senescence-associated endogenous retroviruses by ATF3 drives interferon signaling in aging. Nat. Aging 4, 1794\u20131812 (2024).","journal-title":"Nat. Aging"},{"key":"1810_CR40","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1038\/sj.onc.1202676","volume":"18","author":"SA Amundson","year":"1999","unstructured":"Amundson, S. A. et al. Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene 18, 3666\u20133672 (1999).","journal-title":"Oncogene"},{"key":"1810_CR41","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.4049\/jimmunol.181.7.5089","volume":"181","author":"HH Ho","year":"2008","unstructured":"Ho, H. H., Antoniv, T. T., Ji, J.-D. & Ivashkiv, L. B. Lipopolysaccharide-induced expression of matrix metalloproteinases in human monocytes is suppressed by IFN-\u03b3 via superinduction of ATF-3 and suppression of AP-11. J. Immunol. 181, 5089\u20135097 (2008).","journal-title":"J. Immunol."},{"key":"1810_CR42","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1128\/MCB.24.3.1365-1377.2004","volume":"24","author":"H-Y Jiang","year":"2004","unstructured":"Jiang, H.-Y. et al. Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response. Mol. Cell. Biol. 24, 1365\u20131377 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"1810_CR43","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41589-022-01235-9","volume":"19","author":"TT Le","year":"2023","unstructured":"Le, T. T. et al. Etoposide promotes DNA loop trapping and barrier formation by topoisomerase II. Nat. Chem. Biol. 19, 641\u2013650 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"1810_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat5314","volume":"368","author":"M Costa-Mattioli","year":"2020","unstructured":"Costa-Mattioli, M. & Walter, P. The integrated stress response: From mechanism to disease. Science 368, eaat5314 (2020).","journal-title":"Science"},{"key":"1810_CR45","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fendo.2020.00556","volume":"11","author":"H-C Ku","year":"2020","unstructured":"Ku, H.-C. & Cheng, C.-F. Master regulator activating transcription factor 3 (ATF3) in metabolic homeostasis and cancer. Front. Endocrinol. 11, 556 (2020).","journal-title":"Front. Endocrinol."},{"key":"1810_CR46","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.stem.2021.07.001","volume":"28","author":"SB Larsen","year":"2021","unstructured":"Larsen, S. B. et al. Establishment, maintenance, and recall of inflammatory memory. Cell Stem Cell 28, 1758\u20131774.e8 (2021).","journal-title":"Cell Stem Cell"},{"key":"1810_CR47","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1172\/JCI78954","volume":"125","author":"LN Kwong","year":"2015","unstructured":"Kwong, L. N. et al. Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma. J. Clin. Invest. 125, 1459\u20131470 (2015).","journal-title":"J. Clin. Invest."},{"key":"1810_CR48","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.cell.2020.07.017","volume":"182","author":"A Maynard","year":"2020","unstructured":"Maynard, A. et al. Therapy-induced evolution of human lung cancer revealed by single-cell RNA sequencing. Cell 182, 1232\u20131251.e22 (2020).","journal-title":"Cell"},{"key":"1810_CR49","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41568-024-00737-z","volume":"24","author":"M Russo","year":"2024","unstructured":"Russo, M. et al. Cancer drug-tolerant persister cells: from biological questions to clinical opportunities. Nat. Rev. Cancer 24, 694\u2013717 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"1810_CR50","first-page":"5057","volume":"7","author":"Q Hu","year":"2014","unstructured":"Hu, Q. et al. Elevated cleaved caspase-3 is associated with shortened overall survival in several cancer types. Int. J. Clin. Exp. Pathol. 7, 5057\u20135070 (2014).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"1810_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21549-x","volume":"12","author":"C Yang","year":"2021","unstructured":"Yang, C., Tian, C., Hoffman, T. E., Jacobsen, N. K. & Spencer, S. L. Melanoma subpopulations that rapidly escape MAPK pathway inhibition incur DNA damage and rely on stress signalling. Nat. Commun. 12, 1747 (2021).","journal-title":"Nat. Commun."},{"key":"1810_CR52","doi-asserted-by":"publisher","first-page":"12480","DOI":"10.1073\/pnas.95.21.12480","volume":"95","author":"J Zhang","year":"1998","unstructured":"Zhang, J. et al. Resistance to DNA fragmentation and chromatin condensation in mice lacking the DNA fragmentation factor 45. Proc. Natl Acad. Sci. USA 95, 12480\u201312485 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1810_CR53","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/ni881","volume":"4","author":"K Kawane","year":"2003","unstructured":"Kawane, K. et al. Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation. Nat. Immunol. 4, 138\u2013144 (2003).","journal-title":"Nat. Immunol."},{"key":"1810_CR54","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S1097-2765(04)00258-8","volume":"14","author":"E-J Woo","year":"2004","unstructured":"Woo, E.-J. et al. Structural mechanism for inactivation and activation of CAD\/DFF40 in the apoptotic pathway. Mol. Cell 14, 531\u2013539 (2004).","journal-title":"Mol. Cell"},{"key":"1810_CR55","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nrm1715","volume":"6","author":"K Samejima","year":"2005","unstructured":"Samejima, K. & Earnshaw, W. C. Trashing the genome: the role of nucleases during apoptosis. Nat. Rev. Mol. Cell Biol. 6, 677\u2013688 (2005).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1810_CR56","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15252\/embr.201439366","volume":"16","author":"F Ma","year":"2015","unstructured":"Ma, F. et al. Positive feedback regulation of type I interferon by the interferon-stimulated gene STING. EMBO Rep. 16, 202\u2013212 (2015).","journal-title":"EMBO Rep."},{"key":"1810_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GXY Zheng","year":"2017","unstructured":"Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).","journal-title":"Nat. Commun."},{"key":"1810_CR58","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495\u2013502 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1810_CR59","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1810_CR60","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e21 (2019).","journal-title":"Cell"},{"key":"1810_CR61","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1101\/gr.192237.115","volume":"25","author":"MS Kowalczyk","year":"2015","unstructured":"Kowalczyk, M. S. et al. Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells. Genome Res. 25, 1860\u20131872 (2015).","journal-title":"Genome Res."},{"key":"1810_CR62","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS J. Integr. Biol. 16, 284\u2013287 (2012).","journal-title":"OMICS J. Integr. Biol."},{"key":"1810_CR63","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"1810_CR64","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/s41418-019-0391-9","volume":"27","author":"M Villalobos-Ortiz","year":"2020","unstructured":"Villalobos-Ortiz, M., Ryan, J., Mashaka, T. N., Opferman, J. T. & Letai, A. BH3 profiling discriminates on-target small molecule BH3 mimetics from putative mimetics. Cell Death Differ. 27, 999\u20131007 (2020).","journal-title":"Cell Death Differ."},{"key":"1810_CR65","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"1810_CR66","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491\u2013498 (2011).","journal-title":"Nat. Genet."},{"key":"1810_CR67","unstructured":"van der Auwera, G. A. & O\u2019Connor, B. D. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra (O\u2019Reilly Media, 2020)."},{"key":"1810_CR68","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"1810_CR69","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A., Lin, D.-C., Assenov, Y., Plass, C. & Koeffler, H. P. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28, 1747\u20131756 (2018).","journal-title":"Genome Res."},{"key":"1810_CR70","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41586-023-06621-4","volume":"622","author":"S Victorelli","year":"2023","unstructured":"Victorelli, S. et al. Apoptotic stress causes mtDNA release during senescence and drives the SASP. Nature 622, 627\u2013636 (2023).","journal-title":"Nature"},{"key":"1810_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00809-3","volume":"13","author":"E Kim","year":"2021","unstructured":"Kim, E. & Hart, T. Improved analysis of CRISPR fitness screens and reduced off-target effects with the BAGEL2 gene essentiality classifier. Genome Med. 13, 2 (2021).","journal-title":"Genome Med."}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41556-025-01810-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-025-01810-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-025-01810-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T19:02:29Z","timestamp":1766516549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41556-025-01810-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":71,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1810"],"URL":"https:\/\/doi.org\/10.1038\/s41556-025-01810-x","relation":{},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.J.H. is a cofounder, consultant and research funding recipient of BridgeBio subsidiary Ferro Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}